IFR US ECM Calendar
October 27: MapLight Therapeutics (US, biotech) – $250.8m IPO. 14.8m shares (Primary) at $17.00 fixed price. MS, JEFF, LEER, STFL. Nasdaq "MPLT". Pricing date based on automatic effectiveness 20 days from 10/6 S-1/A filing. T. Rowe Price indicated for $40m of offering. Goldman Sachs affiliate investing $8.1m through a concurrent private placement.
October 30: Navan (US, software) – $960m IPO. 36.9m shares (Primary, Secondary) at $24-$26. GS, CITI. Nasdaq “NAVN”. Pricing date based on automatic effectiveness 20 days from 10/6 S-1/A filing. Selling shareholders led by co-founders Ariel Cohen and Ilan Twig.